Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

Combination Treatment Improves Response to Immunotherapy for Lung Cancer Sep. 25, 2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow ...

Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.